ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Esperion Therapeutics Inc

Esperion Therapeutics Inc (ESPR)

2,47
0,055
(2,28%)
Beim Schlusskurs: 22 November 10:00PM
2,4601
-0,0099
( -0,40% )
Nach Börsenschluss: 12:59AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
2,4601
Gebot
2,46
Fragen
2,50
Volumen
3.108.215
2,35 Tagesbereich 2,51
1,15 52-Wochen-Bereich 3,40
Marktkapitalisierung
Handelsende
2,415
Handelsbeginn
2,39
Letzter Handelszeitpunkt
00:59:22
Finanzvolumen
US$ 7.621.235
VWAP
2,452
Durchschnittliches Volumen (3 Mio.)
3.826.987
Ausgegebene Aktien
197.035.171
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,34
Gewinn pro Aktie (EPS)
-1,06
Erlöse
116,33M
Nettogewinn
-209,25M

Über Esperion Therapeutics Inc

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializi... Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Esperion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ESPR. The last closing price for Esperion Therapeutics was US$2,42. Over the last year, Esperion Therapeutics shares have traded in a share price range of US$ 1,15 to US$ 3,40.

Esperion Therapeutics currently has 197.035.171 shares in issue. The market capitalisation of Esperion Therapeutics is US$475,84 million. Esperion Therapeutics has a price to earnings ratio (PE ratio) of -2.34.

ESPR Neueste Nachrichten

Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference

ANN ARBOR, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Piper Sandler 36th Annual Healthcare...

Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024

– An Exploratory Analysis Reports Patients with PAD Who Took Bempedoic Acid Were 36% Less Likely to Experience a Major Adverse Limb Event Compared to Placebo – ANN ARBOR, Mich., Nov. 18, 2024...

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANN ARBOR, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 7, 2024, the Company granted four new employees 12,900 restricted stock units (RSUs...

Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

– Total Revenue Increased 52% Year-over-Year to $51.6 Million with U.S. Net Product Revenue of $31.1 Million, Representing 53% Growth – – Total Retail Prescription Equivalents Increased 12% and...

Esperion to Participate in Upcoming Jefferies London Healthcare Conference

ANN ARBOR, Mich., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Jefferies London Healthcare Conference on...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.240110.81531531532.222.492.0253728342.23135235CS
40.400119.42233009712.062.61.8751807402.22585875CS
120.770145.56804733731.692.61.5838269872.02677398CS
26-0.0199-0.8024193548392.483.121.5850319692.23037102CS
521.2301100.0081300811.233.41.1558931562.29142925CS
156-5.0199-67.11096256687.4810.020.735331542.84888725CS
260-42.4099-94.517272119544.8779.9890.724027386.33978947CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
VRPXVirpax Pharmaceuticals Inc
US$ 1,14
(93,32%)
12,64M
MTEMMolecular Templates Inc
US$ 0,5818
(53,11%)
12,72M
EYENEyenovia Inc
US$ 0,144
(37,01%)
12,91M
SKKSKK Holdings Limited
US$ 1,48
(34,55%)
6,61M
BENFBeneficient
US$ 1,11
(26,14%)
1,36M
CETXCemtrex Inc
US$ 0,1499
(-23,79%)
4,25M
VINOGaucho Group Holdings Inc
US$ 1,17
(-15,83%)
16,05k
KSCPKnightscope Inc
US$ 15,40
(-15,80%)
52,24k
BTAIBioXcel Therapeutics Inc
US$ 0,49
(-14,13%)
84,7k
LGTYLogility Supply Chain Solutions Inc
US$ 9,66
(-13,75%)
26,45k
ELABElevai Labs Inc
US$ 0,02
(-0,99%)
17,19M
EYENEyenovia Inc
US$ 0,144
(37,01%)
12,91M
MTEMMolecular Templates Inc
US$ 0,5818
(53,11%)
12,72M
VRPXVirpax Pharmaceuticals Inc
US$ 1,14
(93,32%)
12,64M
CDTConduit Pharmaceuticals Inc
US$ 0,105
(-2,69%)
10,33M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock